Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022

August 2012 | 130 pages | ID: L52D587C7CEEN
Visiongain

Abstracts

What are the commercial prospects for pharmaceutical freeze drying? Visiongain's report gives you revenue predictions to 2022 for equipment, services and applications.

You discover the potential of the pharma lyophilisation market, seeing how and why it can grow. Our updated study lets you assess forecasted sales at overall world market, submarket, application and national level.

Our investigation shows you revenue forecasts, growth rates and market shares. You find data, trends, opportunities and industry prospects. Also, you see qualitative analyses (SWOT and STEP) and technological developments.

You receive 50 tables, 33 charts and three research interviews. The following sections highlight what you discover in our report.

YOU FIND PROSPECTS FOR FREEZE DRYING SUBMARKETS AND THERAPEUTIC APPLICATIONS

In addition to analyses of the overall world market, you find revenue forecasting of three world-level submarkets to 2022:

• cGMP lyophilisers
• Laboratory lyophilisers
• Lyophilisation services.

Also, you see how nine drug classes using freeze drying (cryodesiccation) technology can perform to 2022:

• Therapeutic monoclonal antibodies (MAbs)
• Insulins
• Erythropoietins
• Interferons
• G-CSF agents
• Recombinant coagulation factors
• Other therapeutic proteins
• Biosimilars
• Vaccines.

There, you find business research and analysis with sales forecasts and discussions. Our work also breaks overall world revenue into leading national markets.

SEE PROSPECTS FOR LEADING COUNTRIES - WHERE WILL HIGHEST GROWTH OCCUR?

There are many commercial opportunities for lyophilisation technology and services in developed and developing countries. Our study shows you revenue forecasts to 2022 for nine national markets:

• US
• Japan
• Germany, France, UK, Italy and Spain (EU5 nations)
• India and China.

In particular, China and India will show high growth. New biological drugs and vaccines will benefit regional and national markets for those pharmaceutical drying technologies.

PROMINENT ISSUES AFFECTING THE INDUSTRY AND MARKET

Our study lets you assess industry trends and outlooks worldwide from 2012. There, you find discussions of issues and developments:

• Preparation, protection and storage of labile and heat-sensitive drugs
• Injectable solutions, therapeutic proteins, peptides, vaccines other aspects of biopharmaceutical production
• Vials and other consumables for dehydration, including suppliers
• Contract manufacturing organisations (CMOs) providing lyophilisation services
• Operational matters, including challenges in product formulation
• Freeze dryer technologies, including rotary, manifold and tray systems.

You see discussions of technological, commercial and economic developments, with emphasis on organisations competing in the industry.

LEADING COMPANIES AND POTENTIAL FOR MARKET GROWTH

What does the future hold? From 2012 to 2022, the pharmaceutical industry will show rising demand for drying technologies. Lyophilisation revenues will increase.

Our study finds that about 50% of injectable NMEs approved in the next five years will require lyophilisation. Recognition of its importance in stabilising medical products is increasing.

There will be strong sales growth for those drying products and services, including revenues of pharma outsourcing providers, our work shows.

Also, improved drug delivery and new formulations will stimulate demand, as will increasing demand for injectable medicines worldwide - especially biological drugs (biologics) and vaccines. Technology suppliers hold high potential.

In our study you find discussions of these organisations and others:

• GEA Lyophil
• Labconco Corporation
• Vetter Pharma-Fertigung
• Piramal Pharma Solutions (PPS)
• SP Scientific.

Also, you see three interviews with companies. This decade, many opportunities will arise.

EIGHT WAYS LYOPHILISATION FOR PHARMACEUTICALS: PRODUCTS AND SERVICES MARKET 2012-2022 HELPS YOU

To summarise, our report gives you the following knowledge on lyophilisation technology, services and applications:

• Forecasted revenues to 2022 for the overall world market and 3 submarkets
• Potential revenues of 9 therapeutic classes (applications) to 2022
• Market forecasting to 2022 for US, Japan, Germany, France, UK, Spain, Italy (EU5), India and China
• Profiles of 5 leading companies - discussions of activities, products and outlooks
• Opinions on the sector, including our interviews with authorities in industry
• Investigation of competition and opportunities influencing sales
• Discussion of what stimulates and restrains the industry and market
• Prospects for established companies and those seeking to enter the sector.

Contents

1. EXECUTIVE SUMMARY

1.1 Lyophilisation Market Review
1.2 Aims, Scope and Format of the Report
  1.2.1 Chapter Outlines
1.3 Research and Analysis Methods

2. INTRODUCTION TO LYOPHILISATION (FREEZE DRYING)

2.1 Introduction
  2.1.1 What is Freeze Drying?
  2.1.2 Why Freeze Dry?
  2.1.3 A Brief History
2.2 General Description of the Process
  2.2.1 Freezing
  2.2.2 Primary Drying (Sublimation)
  2.2.3 Secondary Drying (Desorption)
2.3 Freeze Drying Equipment
  2.3.1 Components of the Freeze Dryer
    2.3.1.1 Drying Chamber
    2.3.1.2 Condenser
    2.3.1.3 Vacuum Pump
    2.3.1.4 Refrigeration System
    2.3.1.5 Control Facilities
2.4 Type of Freeze Dryers
  2.4.1 Rotary Freeze Dryers
  2.4.2 Manifold Freeze Dryers
  2.4.3 Tray Freeze Dryers
2.5 Applications of Lyophilisation
  2.5.1 Pharmaceutical and Biotechnology Industry
  2.5.2 Other Chemical and Technological Sectors
  2.5.3 Veterinary Applications
  2.5.4 Food Industry Applications
  2.5.5 What Foodstuffs Are Freeze Dried?
  2.5.6 How do Freeze Dryers for Food Differ from Those for Pharmaceutical Applications?
  2.5.7 Other Applications for Lyophilisation

3. LYOPHILISATION TECHNOLOGY AND SERVICES MARKET, 2012-2022

3.1 Scope and Limitations
3.2 The World Lyophilisation Technology and Services Market in 2011
  3.2.1 Prominent Lyophilised Drugs, 2011
  3.2.2 Overall World Lyophilisation Market Value in 2011
3.3 Sales Forecast for Overall Lyophilisation Market, 2011-2016
3.4 Sales Forecast for Overall Lyophilisation Market, 2017-2022
3.5 Breakdown of the World Lyophilisation Market: Main Submarkets
  3.5.1 Sales Forecast for cGMP Lyophilisers, 2012-2022
  3.5.2 Sales Forecast for Laboratory Lyophilisers, 2012-2022
  3.5.3 Sales Forecast for Lyophilisation Services, 2012-2022
3.6 Leading National Markets for Lyophilisation Technology and Services, 2011
  3.6.1 Leading National Markets for Lyophilisation Technology and Services: Sales Forecast, 2012-2022
  3.6.2 The US Lyophilisation Technology and Services Market, 2012-2022
  3.6.3 The Japanese Lyophilisation Technology and Services Market, 2012-2022
  3.6.4 The Leading European Lyophilisation Technology and Services Markets, 2012-2022
  3.6.5 Emerging-Economy Lyophilisation Technology and Services Markets
  3.6.6 The Chinese Lyophilisation Technology and Services Market, 2012-2022
  3.6.7 The Indian Lyophilisation Technology and Services Market, 2012-2022

4. WORLDWIDE MARKET FOR LYOPHILISED PRODUCTS: APPLICATIONS TO 2022

4.1 Therapeutic Areas Offering Growth Opportunities
4.2 Development of Biologics and Vaccines Will Drive the Lyophilisation Market to 2022
4.3 Leading Sectors of the Biological Drugs Market, 2011
  4.3.1 Monoclonal Antibodies Lead the Biotech Market
    4.3.1.1 Long-Term Prospects for Monoclonal Antibodies and Implications for the Lyophilisation Market
  4.3.2 The Human Insulins Class Will Exhibit Strong Growth to 2022
  4.3.3 Erythropoietin Products - How Will Reported Safety Affect Sales?
    4.3.3.1 Erythropoietin Products Forecast, 2012-2022
  4.3.4 The Interferons Class will Show an Increase in Revenues from 2012-2016
    4.3.4.1 Long-Term Forecast for the Interferons Class
  4.3.5 Granular-Colony Stimulating Factors (G-CSF) Market, 2012-2022
  4.3.6 Recombinant Coagulation Factors Will Show Steady Growth
  4.3.7 Other Therapeutic Proteins - Market Prospects to 2022
  4.3.8 Biosimilars Market, 2011
    4.3.8.1 Forecast for the Biosimilars Market, 2012-2022
  4.3.9 Revenue Prospects for the Vaccines Market, 2012-2022
4.4 Applications of Lyophilisation Technology and Services: Conclusions

5. PROMINENT TECHNOLOGY AND SERVICE PROVIDERS IN THE LYOPHILISATION INDUSTRY AND MARKET, 2012

5.1 Products and Services in the Lyophilisation Market in 2012
  5.1.1 Leading Equipment Providers
  5.1.2 Leading Consumables Providers
  5.1.3 Leading Contract Manufacturing Organisations (CMOs) Providing Lyophilisation Services
5.2 Profiles of Some Leading Companies
  5.2.1 GEA Lyophil
    5.2.1.1 Overview
    5.2.1.2 Capabilities of GEA Lyophil
    5.2.1.3 GEA Lyophil's Research and Development Freeze Dryers
    5.2.1.4 GEA Lyophil's Pilot Freeze Dryers
    5.2.1.5 GEA's Lyovac Production Lyophilisers
    5.2.1.6 Lyophilisation Production Systems
    5.2.1.7 GEA's Retrofits of Lyophilisers
    5.2.1.8 GEA's VAPOVAC: Technology for Freeze Dryer Sterilisation
    5.2.1.9 ALUS: GEA Lyophil's Automatic Loading and Unloading Systems for Lyophilisers
    5.2.1.10 GEA's Thermodynamic Lyophilisation Control
    5.2.1.11 GEA Lyophil's Fast Track Project Management
  5.2.2 Labconco Corporation
    5.2.2.1 Overview
    5.2.2.2 Global Presence
    5.2.2.3 Product Focus
    5.2.2.4 Dry Ice Benchtop Freeze Dry System
    5.2.2.5 FreeZone Benchtop Freeze Dry Systems
    5.2.2.6 FreeZone Console Freeze Dry Systems
    5.2.2.7 FreeZone Plus Cascade Freeze Dry Systems
    5.2.2.8 FreeZone Triad Freeze Dry Systems
    5.2.2.9 Labconco Freeze Dry Accessories
    5.2.2.10 R&D
    5.2.2.11 Future Outlook
  5.2.3 Vetter Pharma-Fertigung
    5.2.3.1 Overview
    5.2.3.2 Global Presence
    5.2.3.3 Business Interests
      5.2.3.3.1 Vetter Development Service
      5.2.3.3.2 Vetter Commercial Manufacturing
      5.2.3.3.3 Vetter Solutions
    5.2.3.4 Capabilities
    5.2.3.5 R&D
    5.2.3.6 Product Focus
      5.2.3.6.1 Dual Chamber Technology
    5.2.3.7 Future Outlook
  5.2.4 Piramal Pharma Solutions
    5.2.4.1 Overview
    5.2.4.2 Global Presence
    5.2.4.3 Strengths and Capabilities
  5.2.5 SP Scientific
    5.2.5.1 Overview
    5.2.5.2 Global Presence
    5.2.5.3 Products and Services
    5.2.5.4 Freeze Dryers
    5.2.5.5 SMART Freeze-Dryer Technology
    5.2.5.6 Additional Services
    5.2.5.7 Future Outlook

6. QUALITATIVE ANALYSIS OF THE LYOPHILISATION TECHNOLOGY MARKET, 2012-2022

6.1 Introduction
6.2 Commercial Drivers of the Lyophilisation Technology Market
6.3 Commercial Restraints for the Lyophilisation Technology Market
  6.3.1 High Entry Barriers to Sector
  6.3.2 Product Formulation Challenges
  6.3.3 R&D Stage for Lyophilised Products
  6.3.4 Scale-up Stage for Lyophilised Products
  6.3.5 Main Issues at Large-Scale Production Stage for Lyophilised Products
  6.3.6 Main Challenges in a Freeze Drying Plant
  6.3.7 Main Issues in Production
  6.3.8 Possible Deficiencies in a Freeze Drying Process
6.4 Challenges Facing the Lyophilisation Technology Industry and Market
  6.4.1 Spray Drying of Biopharmaceuticals
  6.4.2 Other Methods in Development
    6.4.2.1 Roche's Precipitation Method

7. OPINIONS FROM OUR SURVEY OF THE INDUSTRY

7.1 Interview with Ms Jennifer Thompson, VP Corporate Development & Investor Relations, EnWave Corporation, and Ms Florian Loesch, Sales Manager, Optima Pharma Group
  7.1.1 Market for Lyophilised Products and Outsourcing of Lyophilisation
  7.1.2 Key Unmet Needs and Driving Forces
  7.1.3 Novel Dehydration Technologies in Development by EnWave Corporation
  7.1.4 Development Status of bioREV and freezeREV Technology
  7.1.5 On the Advantages Offered by bioREV and freezeREV
7.2 Authority from a Company in the Sector (Views Provided Anonymously)
  7.2.1 Market for Lyophilised Products
  7.2.2 Outsourcing of Lyophilisation Work
  7.2.3 Key Unmet Needs and Driving Forces
  7.2.4 On the Capability and Capacity of the CMO
7.3 Interview with Dr Steven Nail, Baxter Healthcare Corporation, USA
  7.3.1 Market Valuation for Freeze Drying?
  7.3.2 Products Suitable for Lyophilisation
  7.3.3 Percentage of Lyophilised Products on Market
  7.3.4 Key Areas for Research and Development
  7.3.5 On Advantages of Lyophilisation
  7.3.6 On Advantages of Lyophilisation over Other Drug Delivery Systems
  7.3.7 On Drawbacks of Lyophilisation over Other Technologies
  7.3.8 On Novel Technologies and Developments

8. CONCLUSIONS OF OUR STUDY

8.1 Overview of Industry and Market
8.2 Prominent Companies in the Market
8.3 Commercial Drivers of the Lyophilisation Market
8.4 Future Outlook and Concluding Remarks

List Of Tables

LIST OF TABLES

Table 3.1 List of Some Lyophilised Orally Disintegrating Tablets, 2012
Table 3.2 World Lyophilisation Market by Leading Categories, 2010 and 2011
Table 3.3 Lyophilisation Technology and Services: World Sales Forecast, 2011-2016
Table 3.4 Lyophilisation Technology and Services: World Sales Forecast, 2017-2022
Table 3.5 Lyophilisation Technology and Services: World Sales Forecasts for Submarkets, 2011-2022
Table 3.6 cGMP Lyophilisers: World Sales Forecast, 2011-2016
Table 3.7 cGMP Lyophilisers: World Sales Forecast, 2017-2022
Table 3.8 Laboratory Lyophilisers: World Sales Forecast, 2011-2016
Table 3.9 Laboratory Lyophilisers: World Sales Forecast, 2017-2022
Table 3.10 Lyophilisation Services Market: World Sales Forecast, 2011-2016
Table 3.11 Lyophilisation Services Market: World Sales Forecast, 2017-2022
Table 3.12 Leading National Markets for Lyophilisation Technology and Services, 2011
Table 3.13 Leading Lyophilisation National Market Forecasts, 2011-2022
Table 3.14 Leading National Markets: Market Shares, 2011, 2016 & 2022
Table 4.1 Leading Therapeutic Classes Driving the Lyophilisation Market, 2011
Table 4.2 Prominent Lyophilised Monoclonal Antibodies, 2012
Table 4.3 Therapeutic Monoclonal Antibodies Market: World Sales Forecast, 2011-2016
Table 4.4 Therapeutic Monoclonal Antibodies Market: World Sales Forecast, 2017-2022
Table 4.5 Insulins Market: World Sales Forecast, 2011-2016
Table 4.6 Insulins Market: World Sales Forecast, 2017-2022
Table 4.7 Erythropoietins Market: World Sales Forecast, 2011-2016
Table 4.8 Erythropoietins Market: World Sales Forecast, 2017-2022
Table 4.9 Prominent Interferon Drugs, 2012
Table 4.10 Interferons Market: World Sales Forecast, 2011-2016
Table 4.11 Interferons Market: World Sales Forecast, 2017-2022
Table 4.12 G-CSF Market: World Sales Forecast, 2011-2016
Table 4.13 G-CSF Market: World Sales Forecast, 2017-2022
Table 4.14 Prominent Recombinant Coagulation Factors, 2012
Table 4.15 Recombinant Coagulation Factors Market: World Sales Forecast, 2011-2016
Table 4.16 Recombinant Coagulation Factors Market: World Sales Forecast, 2017-2022
Table 4.17 Prominent Lyophilised Human Growth Hormones, 2012
Table 4.18 Prominent Lyophilised Immunosuppressants, 2012
Table 4.19 Other Therapeutic Proteins Market: World Sales Forecast, 2011-2016
Table 4.20 Other Therapeutic Proteins Market: World Sales Forecast, 2017-2022
Table 4.21 Prominent Lyophilised Biosimilar Drugs, 2012
Table 4.22 Biosimilars Market: World Sales Forecast, 2011-2016
Table 4.23 Biosimilars Market: World Sales Forecast, 2017-2022
Table 4.24 Prominent Lyophilised Vaccines, 2012
Table 4.25 Vaccines Market: World Sales Forecast, 2011-2016
Table 4.26 Vaccines Market: World Sales Forecast, 2017-2022
Table 5.1 Companies Providing Freeze Dryers and Associated Systems to the Pharmaceutical Industry, 2012
Table 5.2 Companies Providing Vials for Lyophilisation, 2012
Table 5.3 CMOs Providing Lyophilisation Services, 2012
Table 5.4 GEA Pharma Systems: A Historical Perspective
Table 5.5 Labconco Corporation: A Brief History
Table 6.1 Lyophilisation Market: STEP Analysis, 2012-2022
Table 6.2 SWOT Analysis of the Lyophilisation Industry and Market, 2012-2022
Table 6.3 Comparison between Lyophilisation and Spray Drying, 2012
Table 6.4 Advantages of a Spray Dryer for Drying Applications, 2012
Table 8.1 Lyophilisation Market: World Sales Forecasts by Submarket, 2011, 2013, 2016, 2019 and 2022

List Of Figures

LIST OF FIGURES

Figure 2.1 The Primary Steps in Freeze Drying
Figure 2.2 Typical Lyophilisation (Freeze Drying) Process
Figure 2.3 Components of a Typical Freeze Dryer
Figure 3.1 World Lyophilisation Market Shares (%) by Leading Categories, 2011
Figure 3.2 Lyophilisation Technology and Services: World Sales Forecast, 2011-2022
Figure 3.3 Lyophilisation Technology and Services: World Sales Forecasts for Submarkets, 2011-2022
Figure 3.4 cGMP Lyophilisers: World Sales Forecast, 2011-2022
Figure 3.5 Laboratory Lyophilisers: World Sales Forecast, 2011-2022
Figure 3.6 Lyophilisation Services Market: World Sales Forecast, 2011-2022
Figure 3.7 Lyophilisation Sales Shares (%) in Leading National Markets, 2011
Figure 3.8 Lyophilisation Sales Shares (%) in Leading National Markets, 2016
Figure 3.9 Lyophilisation Sales Shares (%) in Leading National Markets, 2022
Figure 3.10 The US Lyophilisation Technology and Services Market Forecast, 2011-2022
Figure 3.11 The Japanese Lyophilisation Technology and Services Market Forecast, 2011-2022
Figure 3.12 Leading European Lyophilisation Technology and Services Markets: Forecasts, 2011-2022
Figure 3.13 The Chinese Lyophilisation Technology and Services Market Forecast, 2011-2022
Figure 3.14 The Indian Lyophilisation Technology and Services Market Forecast, 2011-2022
Figure 4.1 Therapeutic Monoclonal Antibodies Market: World Sales Forecast, 2011-2022
Figure 4.2 Insulins Market: World Sales Forecast, 2011-2022
Figure 4.3 Erythropoietins Market: World Sales Forecast, 2011-2022
Figure 4.4 Interferons Market: World Sales Forecast, 2011-2022
Figure 4.5 G-CSF Market: World Sales Forecast, 2011-2022
Figure 4.6 Recombinant Coagulation Factors Market: World Sales Forecast, 2011-2022
Figure 4.7 Other Therapeutic Proteins Market: World Sales Forecast, 2011-2022
Figure 4.8 Biosimilars Market: World Sales Forecast, 2011-2022
Figure 4.9 Vaccines Market: World Sales Forecast, 2011-2022
Figure 4.10 Top Therapy Classes: World Sales, 2011, 2016 and 2022
Figure 5.1 GEA Lyophil: Opportunities and Threats, 2012-2022
Figure 5.2 Labconco: Opportunities and Threats, 2012-2022
Figure 5.3 Vetter Pharma-Fertigung: Opportunities and Threats, 2012-2022
Figure 5.4 Piramal Healthcare: Opportunities and Threats, 2012-2022
Figure 5.5 SP Scientific: Opportunities and Threats, 2012-2022
Figure 8.1 Lyophilisation Market: World Sales Forecast, 2011, 2013, 2016, 2019 and 2022

COMPANIES LISTED

AAIPharma Services
Abbott
ABC Laboratories
ACMAS Technocracy
Affinity Life Sciences
Albany Molecular Research Inc. (AMRI)
ALK-Abellу
Almac
Althea Technologies
Amgen
Astellas Pharma
Azopharma Product Development Group
B. Braun Melsungen
Baxter BioPharma Solutions
Baxter International
Bayer HealthCare
Bayer HealthCare Pharmaceuticals
Ben Venue Laboratories (a part of Boehringer Ingelheim)
Berna Biotech
Bilcare Global Clinical Supplies
Biogen Idec
BIOLYPH
BioPartners
Biopharma Process Systems
Biopharma Technology
Bio Sidus
Boehringer Ingelheim
Cangene bioPharma
Catalent Pharma Solutions
Centocor Ortho Biotech
Cephalon
Changzhou Yibu Drying Equipment Co.
CIMA Labs
CMC Biologics
Coldstream Laboratories
Cole-Parmer Instrument Company
Corden Pharma
CoreRx Pharmaceuticals
Creapharm
CSL Behring
CSL Biotherapies
CT Arzneimettel
Cuddon Freeze Dry
Dong-A
DSM Pharmaceuticals
EnWave Corporation
E.R. Squibb & Sons
Eli Lilly
European Medicines Agency (EMA)
EMD Serono
Eurogentec
European Freeze Dry
Famar Health Care Services
Food and Drug Administration (US FDA)
Formatech
Freeze Dryer Systems Europe
Freezedry Specialties
Fresenius Kabi Product Partnering
Frozen In Time
Galenix
Gate Pharmaceuticals
GE Healthcare
GEA Group
GEA Lyophil
GEA Niro (a company of the GEA Group)
Genentech (a part of Roche group)
GeneScience
Getz Pharma Research
GIPHARMA
Girindus (a member of the Solvay Group)
Gland Pharma Limited
GlaxoSmithKline
GP Pharm
Grand River Aseptic Manufacturing
Grand River Aseptic Pharmaceutical Packaging
Haemtech Biopharma Services
Haupt Pharma
HollisterStier Contract Manufacturing
HollisterStier Laboratories (a Jubilant Life Sciences company)
Hosokawa Micron Powder Systems
Hospira
Hovione
HTD Biosystems
Huapont Pharm.
Hull (a part of SP industries)
Human Genome Sciences
Hyaluron Contract Manufacturing (HCM)
I.M.A. Industria Macchine Automatiche
IDT Biologika
ilShinBioBase
IMA Edwards Pharmaceutical Systems
Immunex Corporation
Impact Analytical
Intas Biophrmaceuticals
Intelligent Pharma
Irvine Pharmaceutical Services
Janssen Cilag
JHP Pharmaceuticals
JOUAN Nordic A/S
KBI Biopharma
King Pharmaceuticals
KP Pharmaceutical Technology
Lab. PiSA
Labconco Corporation
Lampire Biological Laboratories
Legacy Pharmaceuticals International
LG Life Sciences
LifeScientz Bio-tech Company
Lonza
Lyka Labs
Lyofal
Lyophilization Services of New England (LSNE)
Lyophilization Technology
Martin Christ Gefriertrocknungsanlagen
MechaTech Systems
MedPharm
Merck & Co.
Merck Sharp & Dohme
Merk Process
Millrock Technology
Miltenyi Biotec
Ministry of Health, Labour and Welfare (MHLW, Japan)
Molecular Profiles
Nextar Chempharma Solutions
NextPharma Technologies
Nicholas Piramal
Niro A/S
Novartis
Novartis Vaccines and Diagnostics
Novo Nordisk
Nycomed
Oakwood Laboratories
OctoPlus N.V.
Om Bhagwati Labelling Technologies
Omnia Biologics
One 2 One
Optima Pharma Group
Optima Machinery Corporation
Oregon Freeze Dry
Organon Teknika Corporation
Osaka University
Oso BioPharmaceuticals Manufacturing
Overlook Industries
Patheon
Peptisyntha (a part of Solvay Group)
Pfizer
Pfizer CentreSource (PCS)
Pharmatek Laboratories
PharmIdea
Piramal Healthcare
Piramal Pharma Solutions
PolyPeptide Laboratories
ProJect Pharmaceutics
Purdue University
Pyramid Laboratories
Quality Assistance SA
Quorum Technologies
Recipharm Cobra Bio
Regeneron Pharmaceuticals
Reig Jofre Group
RFCL
Richman Chemical
RK Medicare Private Limited
Roche
Roch Mechatronics
SAFC
Sandoz (a Novartis company)
Sanofi
Sanofi Pasteur
Schering Corporation (a subsidiary of Merck & Co.)
Schering-Plough HealthCare Products
Schott
Scripps Laboratories
Serail
Serail Freeze-Drying Systems
SGD Pharma
SL Pharma Labs
Solvay
SP Formulations
SP Industries
SP Scientific
SPI Pharmaceuticals
SRI International
Stason Pharmaceuticals
Talecris Biotherapeutics
Telstar
Teva Pharmaceutical Industries
Therapure Biopharma
Thermo Fisher Scientific
UCB
University of Connecticut
University of Iowa Pharmaceuticals (UIP)
USIFROID (a Telstar company)
Valeant Pharmaceuticals International
Vectech
Vetter Pharma-Fertigung
Vetter Pharma International
Walter Reed Pilot Bioproduction Facility
West Pharmaceutical Services
Wheaton Science Products
Wockhardt
Wyeth Pharmaceuticals (a subsidiary of Pfizer)
Xellia Pharmaceuticals
Zirbus Technology